Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,196 | 64 | 83.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $130.00 | 1 | 9.0% |
| Education | $113.88 | 2 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $411.22 | 22 | $0 (2020) |
| Janssen Biotech, Inc. | $271.72 | 12 | $0 (2021) |
| PFIZER INC. | $161.84 | 8 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $130.00 | 1 | $0 (2017) |
| AbbVie, Inc. | $78.48 | 5 | $0 (2018) |
| NeoTract Inc. | $78.27 | 3 | $0 (2020) |
| Endo Pharmaceuticals Inc. | $70.51 | 4 | $0 (2021) |
| ROCHESTER MEDICAL CORPORATION | $55.50 | 2 | $0 (2019) |
| Boston Scientific Corporation | $53.22 | 2 | $0 (2019) |
| Egalet US Inc | $20.99 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $57.11 | 3 | Janssen Biotech, Inc. ($22.59) |
| 2020 | $73.33 | 3 | NeoTract Inc. ($54.47) |
| 2019 | $392.71 | 17 | Astellas Pharma US Inc ($168.65) |
| 2018 | $323.69 | 20 | Astellas Pharma US Inc ($147.31) |
| 2017 | $592.65 | 24 | Janssen Biotech, Inc. ($197.13) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2021 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: UROLOGY | ||||||
| 06/18/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Oncology | ||||||
| 01/06/2021 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/28/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $38.06 | General |
| Category: Interventional Urology | ||||||
| 07/15/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: ONCOLOGY | ||||||
| 06/22/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Interventional Urology | ||||||
| 12/18/2019 | Boston Scientific Corporation | AMS (Device) | Food and Beverage | In-kind items and services | $40.13 | General |
| Category: ERECTILE DYSFUNCTION | ||||||
| 11/21/2019 | ROCHESTER MEDICAL CORPORATION | — | Food and Beverage | In-kind items and services | $28.00 | General |
| 09/19/2019 | ROCHESTER MEDICAL CORPORATION | — | Food and Beverage | In-kind items and services | $27.50 | General |
| 05/28/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: UROLOGY | ||||||
| 05/09/2019 | Astellas Pharma US Inc | — | Education | In-kind items and services | $69.99 | General |
| 05/07/2019 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $43.89 | General |
| Category: ONCOLOGY | ||||||
| 05/07/2019 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 04/16/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: ONCOLOGY | ||||||
| 04/15/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Oncology | ||||||
| 04/09/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $1.70 | General |
| Category: ONCOLOGY | ||||||
| 03/22/2019 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological), EDEX, AVEED | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: UROLOGY | ||||||
| 03/12/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: ONCOLOGY | ||||||
| 03/05/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Oncology | ||||||
| 02/22/2019 | Metuchen Pharmaceuticals | Stendra (Drug) | Food and Beverage | Cash or cash equivalent | $17.59 | General |
| Category: Erectile Dysfunction | ||||||
| 02/19/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: UROLOGY | ||||||
| 02/12/2019 | Boston Scientific Corporation | REZUM (Device) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: PROSTATE HEALTH | ||||||
| 01/15/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2018 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2018 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 18 | 911 | 1,415 | $255,511 | $75,360 |
| 2021 | 42 | 3,672 | 9,278 | $1.4M | $399,648 |
| 2020 | 40 | 3,521 | 6,643 | $1.6M | $388,327 |
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 315 | 386 | $78,095 | $23,210 | 29.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 63 | 64 | $41,600 | $13,771 | 33.1% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2022 | 21 | 286 | $31,460 | $9,990 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 81 | $24,381 | $7,314 | 30.0% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2022 | 21 | 66 | $13,860 | $4,612 | 33.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 89 | 92 | $11,224 | $3,568 | 31.8% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2022 | 17 | 90 | $9,900 | $3,144 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $13,677 | $2,583 | 18.9% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 14 | 14 | $5,810 | $1,943 | 33.4% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2022 | 21 | 22 | $2,420 | $768.48 | 31.8% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2022 | 21 | 22 | $2,420 | $768.48 | 31.8% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2022 | 21 | 22 | $2,420 | $768.48 | 31.8% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2022 | 21 | 22 | $2,420 | $768.48 | 31.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 68 | 76 | $9,500 | $690.18 | 7.3% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2022 | 17 | 18 | $1,980 | $628.82 | 31.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 11 | 23 | $1,725 | $431.61 | 25.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 78 | 88 | $968.00 | $304.98 | 31.5% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 12 | 13 | $1,651 | $94.23 | 5.7% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2021 | 154 | 1,531 | $168,410 | $53,723 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 435 | 577 | $116,554 | $42,742 | 36.7% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2021 | 154 | 541 | $113,610 | $37,978 | 33.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 140 | 158 | $102,700 | $35,219 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 268 | 317 | $95,417 | $34,739 | 36.4% |
| 87150 | Identification of organisms by genetic analysis, amplified probe technique | Office | 2021 | 69 | 924 | $101,640 | $32,423 | 31.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 155 | 155 | $71,765 | $21,615 | 30.1% |
About Dr. Yousef Salem, MD
Dr. Yousef Salem, MD is a Urology healthcare provider based in Alexandria, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134108939.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yousef Salem, MD has received a total of $1,439 in payments from pharmaceutical and medical device companies, with $57.11 received in 2021. These payments were reported across 67 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,196).
As a Medicare-enrolled provider, Salem has provided services to 8,104 Medicare beneficiaries, totaling 17,336 services with total Medicare billing of $863,335. Data is available for 3 years (2020–2022), covering 100 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Alexandria, VA
- Active Since 01/11/2006
- Last Updated 06/26/2019
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1134108939
Products in Payments
- XTANDI (Drug) $295.02
- ZYTIGA (Drug) $197.13
- JEVTANA (Drug) $130.00
- MYRBETRIQ (Drug) $104.13
- Androgel (Drug) $78.48
- XIAFLEX (Biological) $70.51
- UroLift (Device) $54.47
- Erleada (Drug) $52.00
- Myrbetriq (Drug) $41.86
- AMS (Device) $40.13
- Xtandi (Drug) $34.54
- Urolift - UL400 (Device) $23.80
- ERLEADA (Drug) $22.59
- SPRIX (Drug) $20.99
- BOTOX THERAPEUTIC (Biological) $18.57
- Rezum (Device) $18.52
- Stendra (Drug) $17.59
- JELMYTO (Drug) $16.34
- SUTENT (Drug) $16.26
- MAGIC3 (Device) $14.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Alexandria
Dr. Gregory Bernstein, Md, MD
Urology — Payments: $20,090
James Richey, M.d, M.D
Urology — Payments: $7,883
Dr. Robert Fontane, M.d, M.D
Urology — Payments: $6,727
Joshua Holstead, Md, MD
Urology — Payments: $6,696
Lance Templeton, M.d, M.D
Urology — Payments: $6,397
Dr. Jeffrey Wong, M.d, M.D
Urology — Payments: $5,180